Tech Company Financing Transactions
CardiaTec Funding Round
On 9/9/2024, CardiaTec announced $6.5 million in Seed funding from Montage Ventures, APEX Ventures and Continuum Health Ventures.
Transaction Overview
Company Name
Announced On
9/9/2024
Transaction Type
Venture Equity
Amount
$6,500,000
Round
Seed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
9 Hills Road
Cambridge, Cambridgeshire, CB2 1GE
UK
Cambridge, Cambridgeshire, CB2 1GE
UK
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
CardiaTec is a TechBio company employing computational methods to decode the biology behind cardiovascular disease. We leverage large and high-dimensional human omics data to better navigate complex disease biology to discover novel and differentiated therapeutics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Raphael Peralta
Chief Operating Officer
Thelma Zablocki
Chief Technical Officer
Namshik Han
Browse more venture capital transactions:
Prev: 9/9/2024: Bambusa Therapeutics venture capital transaction
Next: 9/9/2024: Constantiam Biosciences venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. All VC database entries reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs